ChemoCentryx Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and ChemoCentryx are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days ChemoCentryx has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, ChemoCentryx is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Quick Ratio | 4.38 | |
| Fifty Two Week Low | 14.95 | |
| Target High Price | 52.00 | |
| Fifty Two Week High | 52.00 | |
| Target Low Price | 52.00 |
ChemoCentryx |
ChemoCentryx Relative Risk vs. Return Landscape
If you would invest (100.00) in ChemoCentryx on September 29, 2025 and sell it today you would earn a total of 100.00 from holding ChemoCentryx or generate -100.0% return on investment over 90 days. ChemoCentryx is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than ChemoCentryx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ChemoCentryx Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ChemoCentryx's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ChemoCentryx, and traders can use it to determine the average amount a ChemoCentryx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CCXI |
Based on monthly moving average ChemoCentryx is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ChemoCentryx by adding ChemoCentryx to a well-diversified portfolio.
ChemoCentryx Fundamentals Growth
ChemoCentryx Stock prices reflect investors' perceptions of the future prospects and financial health of ChemoCentryx, and ChemoCentryx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ChemoCentryx Stock performance.
| Return On Equity | -46.96 | |||
| Return On Asset | -18.55 | |||
| Operating Margin | (353.17) % | |||
| Current Valuation | 3.45 B | |||
| Shares Outstanding | 70.03 M | |||
| Price To Earning | 40.53 X | |||
| Price To Book | 10.04 X | |||
| Price To Sales | 97.66 X | |||
| Revenue | 37.28 M | |||
| EBITDA | (127.6 M) | |||
| Cash And Equivalents | 328.62 M | |||
| Cash Per Share | 4.61 X | |||
| Total Debt | 73.2 M | |||
| Debt To Equity | 0.31 % | |||
| Book Value Per Share | 5.18 X | |||
| Cash Flow From Operations | (53.5 M) | |||
| Earnings Per Share | (0.94) X | |||
| Total Asset | 78.16 M | |||
| Retained Earnings | (441.3 M) | |||
| Current Asset | 72.03 M | |||
| Current Liabilities | 5.49 M | |||
Things to note about ChemoCentryx performance evaluation
Checking the ongoing alerts about ChemoCentryx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ChemoCentryx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ChemoCentryx is not yet fully synchronised with the market data | |
| ChemoCentryx has some characteristics of a very speculative penny stock | |
| ChemoCentryx has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 37.28 M. Net Loss for the year was (133.09 M) with loss before overhead, payroll, taxes, and interest of (51.07 M). | |
| ChemoCentryx currently holds about 328.62 M in cash with (53.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.61. | |
| Over 84.0% of the company shares are held by institutions such as insurance companies |
- Analyzing ChemoCentryx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ChemoCentryx's stock is overvalued or undervalued compared to its peers.
- Examining ChemoCentryx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ChemoCentryx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ChemoCentryx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ChemoCentryx's stock. These opinions can provide insight into ChemoCentryx's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in ChemoCentryx Stock
If you are still planning to invest in ChemoCentryx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ChemoCentryx's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |